Warrant
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 25 of Bolt Biotherapeutics, Inc.'s SEC filings and found 1 warrant series, 2 convertibles and 2 completed offerings on file for BOLT. The latest dilution event on file is an offering on Oct 23, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 11 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Oct 23, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z